-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Maintains Buy on Veracyte, Lowers Price Target to $40

Benzinga·11/10/2026 12:44:17
Listen to the news
Freedom Capital Markets analyst Keith Hinton maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $66 to $40.